RPRX stock – News Heater

Companies

Royalty Pharma plc’s (RPRX) Stock: A 61.03% Annual Performance Rate

The stock of Royalty Pharma plc (RPRX) has gone down by -3.39% for the week, with a -5.36% drop in the past month and a

Business

Royalty Pharma plc (RPRX) Stock: A Value Analysis

The price-to-earnings ratio for Royalty Pharma plc (NASDAQ: RPRX) is 11.53x, which is above its average ratio. Moreover, the 36-month beta value for RPRX is

Hot Stocks

Royalty Pharma plc (RPRX) Beta Value: Understanding the Market Risk

The price-to-earnings ratio for Royalty Pharma plc (NASDAQ: RPRX) is above average at 11.61x. The 36-month beta value for RPRX is also noteworthy at 0.45.

Hot Stocks

Royalty Pharma plc (RPRX) Stock: A Look at the Analyst Recommendations

Royalty Pharma plc (NASDAQ: RPRX) has a higher price-to-earnings ratio of 12.01x compared to its average ratio. RPRX has 36-month beta value of 0.45. Analysts

Business

Royalty Pharma plc (RPRX) Shares Up Despite Recent Market Volatility

The stock price of Royalty Pharma plc (NASDAQ: RPRX) has surged by 0.43 when compared to previous closing price of 30.05, but the company has

Tag: RPRX stock

Royalty Pharma plc’s (RPRX) Stock: A 61.03% Annual Performance Rate

Royalty Pharma plc (RPRX) Stock: A Value Analysis

Royalty Pharma plc (RPRX) Beta Value: Understanding the Market Risk

Royalty Pharma plc (RPRX) Stock: A Look at the Analyst Recommendations

Royalty Pharma plc (RPRX) Shares Up Despite Recent Market Volatility

Navigation

Newsletter